Compounds > dideoxyadenosine
Page last updated: 2024-08-22

dideoxyadenosine and coformycin

dideoxyadenosine has been researched along with coformycin in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19905 (71.43)18.7374
1990's2 (28.57)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Plagemann, PG; Woffendin, C1
Fridland, A; Johns, DG; Johnson, MA1
Beardsley, GP; Broder, S; Cooney, D; Duff, R; Landau, NR; McCaffrey, R; Mitsuya, H; Spigelman, Z; Ullman, B1
Baba, M; Balzarini, J; de Clercq, E; Herdewijn, P; Pauwels, R; Robins, MJ; Wood, SG1
Carrera, CJ; Carson, DA; Haertle, T; Richman, DD; Sowers, LC; Wasson, DB1
Koç, Y; McCaffrey, R1
Cristalli, G; Franchetti, P; Grifantini, M; La Colla, P; Marongiu, ME; Pani, A; Tinti, E1

Other Studies

7 other study(ies) available for dideoxyadenosine and coformycin

ArticleYear
Permeation and salvage of dideoxyadenosine in mammalian cells.
    Molecular pharmacology, 1989, Volume: 36, Issue:1

    Topics: Animals; Carrier Proteins; Coformycin; Deamination; Dideoxyadenosine; Dideoxynucleosides; Erythrocytes; Humans; Leukemia, Experimental; Membrane Proteins; Mice; Nucleoside Transport Proteins; Pentostatin; Permeability; Zalcitabine

1989
2',3'-Dideoxynucleoside phosphorylation by deoxycytidine kinase from normal human thymus extracts: activation of potential drugs for AIDS therapy.
    Biochemical and biophysical research communications, 1987, Nov-13, Volume: 148, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Coformycin; Deoxyadenosines; Deoxycytidine; Deoxycytidine Kinase; Dideoxyadenosine; Humans; Kinetics; Pentostatin; Phosphorylation; Phosphotransferases; Structure-Activity Relationship; Thymus Extracts; Thymus Gland; Zalcitabine

1987
2',3'-Dideoxyadenosine is selectively toxic for TdT-positive cells.
    Blood, 1988, Volume: 71, Issue:6

    Topics: Cell Division; Cells, Cultured; Coformycin; Deoxyadenosines; Dideoxyadenosine; DNA Nucleotidylexotransferase; DNA Nucleotidyltransferases; DNA Polymerase II; Endonucleases; Humans; In Vitro Techniques; Substrate Specificity

1988
Potent and selective activity of 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside, 3'-fluoro-2,6-diaminopurine-2',3'-dideoxyriboside, and 3'-fluoro-2',3'-dideoxyguanosine against human immunodeficiency virus.
    Molecular pharmacology, 1988, Volume: 33, Issue:3

    Topics: Adenosine Deaminase; Antimetabolites; Antiviral Agents; Coformycin; Deoxyadenosines; Deoxyguanosine; Dideoxyadenosine; Dideoxynucleosides; HIV; Pentostatin; Prodrugs; Solubility; Virus Replication

1988
Metabolism and anti-human immunodeficiency virus-1 activity of 2-halo-2',3'-dideoxyadenosine derivatives.
    The Journal of biological chemistry, 1988, Apr-25, Volume: 263, Issue:12

    Topics: Adenosine Deaminase Inhibitors; AMP Deaminase; Cell Line; Coformycin; Deoxyadenosines; Deoxycytidine Kinase; Dideoxyadenosine; Dideoxynucleosides; HIV; Humans; Phosphorylation; T-Lymphocytes; Virus Replication

1988
2',3'-Dideoxyadenosine killing of TdT-positive cells is due to a trace contaminant.
    Leukemia, 1995, Volume: 9, Issue:1

    Topics: Cell Survival; Coformycin; Deoxyadenosines; Dideoxyadenosine; DNA Nucleotidylexotransferase; Humans; Tumor Cells, Cultured

1995
Enhancement of the anti-HIV-1 activity of ddAdo by coformycin, EHNA and deaza-EHNA derivatives.
    The new microbiologica, 1995, Volume: 18, Issue:4

    Topics: Adenine; Adenosine Deaminase Inhibitors; Antiviral Agents; Cell Line; Coformycin; Dideoxyadenosine; Drug Evaluation, Preclinical; Drug Synergism; Enzyme Inhibitors; HIV-1; Humans; Virus Replication

1995